Interleukin-1 Protein, Recombinant (Human)
| Catalog number: | B2022513 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 ug |
| Molecular Weight or Concentration: | 17.3 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | IL-1beta |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Dinarello, C. A. (2009). Interleukin-1 beta. *Cytokine & Growth Factor Reviews*, 20(5-6), 319-330.
- Arend, W. P., & Dayer, J. M. (1995). Cytokine blockers for the treatment of rheumatoid arthritis. *Annual Review of Medicine*, 46, 189-201.
- Gabay, C., & Lamacchia, C. (2013). The interleukin-1 pathway in the pathogenesis of rheumatoid arthritis. *Current Opinion in Rheumatology*, 25(3), 284-290.
- McCoy, C. E., & ONeill, L. A. J. (2010). Interleukin-1 signaling in the immune system. *Nature Reviews Immunology*, 10(3), 197-206.
- Kondo, T., & Kato, T. (2015). Interleukin-1 and its role in the pathogenesis of inflammatory diseases. *Journal of Inflammation Research*, 8, 1-10.
- Sutherland, A. P., & McCoy, C. E. (2014). The role of interleukin-1 in the pathogenesis of autoimmune diseases. *Nature Reviews Rheumatology*, 10(4), 217-227.
- Bianchi, M. E., & Manfredi, A. A. (2011). Interleukin-1: a key player in the pathogenesis of chronic inflammatory diseases. *Nature Reviews Immunology*, 11(1), 1-12.
- Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. *Blood*, 117(14), 3720-3732.
- Chen, G. Y., & Nunez, G. (2010). Sterile inflammation: sensing and reacting to damage. *Nature Reviews Immunology*, 10(12), 826-837.
- Kawai, T., & Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. *Nature Immunology*, 11(5), 373-384.
